Aghajanian C - Search Results

1

Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer.

Liu YL, Zhou Q, Iasonos A, Emengo VN, Friedman C, Konner JA, O'Cearbhaill RE, Aghajanian C, Zamarin D. Liu YL, et al. Among authors: aghajanian c. Gynecol Oncol. 2019 Oct;155(1):51-57. doi: 10.1016/j.ygyno.2019.08.006. Epub 2019 Aug 14. Gynecol Oncol. 2019. PMID: 31421916 Free PMC article.

2

Metastatic breast carcinoma to the abdomen and pelvis.

Abu-Rustum NR, Aghajanian CA, Venkatraman ES, Feroz F, Barakat RR. Abu-Rustum NR, et al. Among authors: aghajanian ca. Gynecol Oncol. 1997 Jul;66(1):41-4. doi: 10.1006/gyno.1997.4720. Gynecol Oncol. 1997. PMID: 9234919

3

Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-up.

Barakat RR, Sabbatini P, Bhaskaran D, Revzin M, Smith A, Venkatraman E, Aghajanian C, Hensley M, Soignet S, Brown C, Soslow R, Markman M, Hoskins WJ, Spriggs D. Barakat RR, et al. Among authors: aghajanian c. J Clin Oncol. 2002 Feb 1;20(3):694-8. doi: 10.1200/JCO.2002.20.3.694. J Clin Oncol. 2002. PMID: 11821450

4

Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after the development of a carboplatin allergy.

Dizon DS, Sabbatini PJ, Aghajanian C, Hensley ML, Spriggs DR. Dizon DS, et al. Among authors: aghajanian c. Gynecol Oncol. 2002 Mar;84(3):378-82. doi: 10.1006/gyno.2001.6519. Gynecol Oncol. 2002. PMID: 11855873

5

Retrospective analysis of carboplatin and paclitaxel as initial second-line therapy for recurrent epithelial ovarian carcinoma: application toward a dynamic disease state model of ovarian cancer.

Dizon DS, Hensley ML, Poynor EA, Sabbatini P, Aghajanian C, Hummer A, Venkatraman E, Spriggs DR. Dizon DS, et al. Among authors: aghajanian c. J Clin Oncol. 2002 Mar 1;20(5):1238-47. doi: 10.1200/JCO.2002.20.5.1238. J Clin Oncol. 2002. PMID: 11870166

6

Craniotomy for central nervous system metastases in epithelial ovarian carcinoma.

Pothuri B, Chi DS, Reid T, Aghajanian C, Venkatraman E, Alektiar K, Bilsky M, Barakat RR. Pothuri B, et al. Among authors: aghajanian c. Gynecol Oncol. 2002 Oct;87(1):133-7. doi: 10.1006/gyno.2002.6792. Gynecol Oncol. 2002. PMID: 12468354

7

Palliative surgery for bowel obstruction in recurrent ovarian cancer:an updated series.

Pothuri B, Vaidya A, Aghajanian C, Venkatraman E, Barakat RR, Chi DS. Pothuri B, et al. Among authors: aghajanian c. Gynecol Oncol. 2003 May;89(2):306-13. doi: 10.1016/s0090-8258(03)00073-8. Gynecol Oncol. 2003. PMID: 12713996

8

Platinum retreatment of platinum-resistant ovarian cancer after nonplatinum therapy.

Leitao MM Jr, Hummer A, Dizon DS, Aghajanian C, Hensley M, Sabbatini P, Venkatraman E, Spriggs DR. Leitao MM Jr, et al. Among authors: aghajanian c. Gynecol Oncol. 2003 Oct;91(1):123-9. doi: 10.1016/s0090-8258(03)00464-5. Gynecol Oncol. 2003. PMID: 14529671

9

Treatment of recurrent ovarian cancer: a retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel. The Memorial Sloan-Kettering Cancer Center experience.

Dizon DS, Dupont J, Anderson S, Sabbatini P, Hummer A, Aghajanian C, Spriggs D. Dizon DS, et al. Among authors: aghajanian c. Gynecol Oncol. 2003 Dec;91(3):584-90. doi: 10.1016/j.ygyno.2003.08.017. Gynecol Oncol. 2003. PMID: 14675681

10

Costs of treatment and outcomes associated with second-line therapy and greater for relapsed ovarian cancer.

Prasad M, Ben-Porat L, Hoppe B, Aghajanian C, Sabbatini P, Chi DS, Hensley ML. Prasad M, et al. Among authors: aghajanian c. Gynecol Oncol. 2004 Apr;93(1):223-8. doi: 10.1016/j.ygyno.2004.01.014. Gynecol Oncol. 2004. PMID: 15047240

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

314 results

Search Page

Filters